Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Biopharmaceutical Companies 2026
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2026, World Top Biopharmaceutical Companies by Market Cap in 2026.
  1. Forte Biosciences Inc.

    World Rank (Aug-2026)
    7,130
    Market Cap (Aug-2026)
    1.631 Billion USD
    World Rank (Jan-05-2024)
    27,186
    Market Cap (Jan-05-2024)
    0.030 Billion USD
    World Rank (Jul-30-2023)
    29,222
    Market Cap (Jul-30-2023)
    0.021 Billion USD
    World Rank (Dec-25-2022)
    29,143
    Market Cap (Dec-25-2022)
    0.021 Billion USD
    World Rank (Jan-07-2022)
    28,669
    Market Cap (Jan-07-2022)
    0.03 Billion USD
    Annual Operating Income in USD
    -71 Million USD
    Annual Net Income in USD
    -69 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Forte Biosciences, Inc. is a clinical stage biopharmaceutical company focused on dermatology. The company total assets are 61.2 million USD a son 2020. The headquarters is in USA.
  2. Cincor Pharma Inc.

    World Rank (Aug-2026)
    7,569
    World Rank (Jan-05-2024)
    7,569
    World Rank (Jul-30-2023)
    7,569
    Market Cap (Jul-30-2023)
    1.270 Billion USD
    World Rank (Dec-25-2022)
    12,352
    Market Cap (Dec-25-2022)
    0.504 Billion USD
    World Rank (Jan-07-2022)
    10,873
    Annual Operating Income in USD
    -43 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    Company Profile
    CinCor Pharma Inc is a clinical stage biopharmaceutical company focused on developing lead clinical candidate, baxdrostat (CIN-107), for the treatment of hypertension and other cardio-renal diseases. The headquarters is in United States.
  3. Oric Pharmaceuticals Inc.

    World Rank (Aug-2026)
    7,628
    Market Cap (Aug-2026)
    1.438 Billion USD
    World Rank (Jan-05-2024)
    12,752
    Market Cap (Jan-05-2024)
    0.489 Billion USD
    World Rank (Jul-30-2023)
    14,604
    Market Cap (Jul-30-2023)
    0.372 Billion USD
    World Rank (Dec-25-2022)
    17,297
    Market Cap (Dec-25-2022)
    0.229 Billion USD
    World Rank (Jan-07-2022)
    12,703
    Market Cap (Jan-07-2022)
    0.56 Billion USD
    Annual Operating Income in USD
    -143 Million USD
    Annual Net Income in USD
    -129 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    ORIC Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on discovering and developing innovative therapies that benefit patients with cancer. The company annual revenue is 1.07 billion USD and 60 employees as on 2019. The headquarters is in USA.
  4. MoonLake Immunotherapeutics

    World Rank (Aug-2026)
    7,733
    Market Cap (Aug-2026)
    1.402 Billion USD
    World Rank (Jan-05-2024)
    3,968
    Market Cap (Jan-05-2024)
    3.404 Billion USD
    World Rank (Jul-30-2023)
    4,196
    Market Cap (Jul-30-2023)
    3.164 Billion USD
    World Rank (Dec-25-2022)
    14,035
    Market Cap (Dec-25-2022)
    0.390 Billion USD
    Headquarters Country
    Company Profile
    MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.
  5. Intrexon Corporation

    World Rank (Aug-2026)
    7,914
    World Rank (Jan-05-2024)
    7,914
    World Rank (Jul-30-2023)
    7,914
    World Rank (Dec-25-2022)
    7,914
    World Rank (Jan-07-2022)
    7,914
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -111 Million USD
    Annual Net Income in USD
    -251 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Precigen is a Dedicated Discovery and Clinical Stage Biopharmaceutical company. It is advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno oncology, autoimmune disorders and infectious diseases. The headquarters is in USA.
    Facts About Company
    The company annual revenue is 90.7 million USD and 601 employees as on 2020.
  6. Inhibrx Inc.

    World Rank (Aug-2026)
    8,088
    Market Cap (Aug-2026)
    1.296 Billion USD
    World Rank (Jan-05-2024)
    6,046
    Market Cap (Jan-05-2024)
    1.809 Billion USD
    World Rank (Jul-30-2023)
    7,998
    World Rank (Dec-25-2022)
    7,998
    Market Cap (Dec-25-2022)
    1.081 Billion USD
    World Rank (Jan-07-2022)
    8,138
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Operating Income in USD
    -135 Million USD
    Annual Net Income in USD
    -140 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Inhibrx is a Clinical Stage Biotechnology company developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of core sdAb (single-domain antibody) platform and protein engineering expertise. The company annual revenue is 34.1 million USD and 80 employees as on 2020. The headquarters is in USA.
  7. MannKind Corporation

    World Rank (Aug-2026)
    8,298
    Market Cap (Aug-2026)
    1.238 Billion USD
    World Rank (Jan-05-2024)
    8,442
    Market Cap (Jan-05-2024)
    1.030 Billion USD
    World Rank (Jul-30-2023)
    7,743
    Market Cap (Jul-30-2023)
    1.224 Billion USD
    World Rank (Dec-25-2022)
    7,058
    Market Cap (Dec-25-2022)
    1.340 Billion USD
    World Rank (Jan-07-2022)
    9,303
    Market Cap (Jan-07-2022)
    1.02 Billion USD
    Annual Revenue in USD
    349 Million USD
    Annual Operating Income in USD
    39 Million USD
    Annual Net Income in USD
    6 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Mankind Corporation is a biopharmaceutical company with headquarters is in California, USA. It develops cutting-edge therapeutic products and technologies that help people take control of their health.
  8. Brooklyn Immunotherapeutics Inc.

    World Rank (Aug-2026)
    8,971
    Market Cap (Aug-2026)
    1.063 Billion USD
    World Rank (Jan-05-2024)
    18,926
    World Rank (Jul-30-2023)
    18,926
    World Rank (Dec-25-2022)
    18,926
    World Rank (Jan-07-2022)
    18,926
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Annual Operating Income in USD
    -9 Million USD
    Annual Net Income in USD
    -14 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Brooklyn ImmunoTherapeutics is a Clinical Stage Biopharmaceutical company committed to creating a world where patients and families with high unmet medical needs have access to effective treatments. The company annual revenue is 5.8 million USD. The headquarters is in USA.
  9. Avalo Therapeutics Inc.

    World Rank (Aug-2026)
    9,013
    Market Cap (Aug-2026)
    1.051 Billion USD
    World Rank (Jan-05-2024)
    31,979
    Market Cap (Jan-05-2024)
    0.007 Billion USD
    World Rank (Jul-30-2023)
    33,602
    Market Cap (Jul-30-2023)
    0.003 Billion USD
    World Rank (Dec-25-2022)
    25,537
    Market Cap (Dec-25-2022)
    0.047 Billion USD
    World Rank (Jan-07-2022)
    21,658
    Market Cap (Jan-07-2022)
    0.12 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -73 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Avalo Therapeutics, Inc. is a biopharmaceutical company that discover, develop and commercialize highly targeted therapeutics in areas of significant unmet clinical need. The headquarters is in USA.
    Facts About Company
    Avalo Therapeutics, Inc. company annual revenue is 18 million USD and annual net loss -41 million USD as on Dec-2022.
  10. Lexicon Pharmaceuticals

    World Rank (Aug-2026)
    9,111
    Market Cap (Aug-2026)
    1.032 Billion USD
    World Rank (Jan-05-2024)
    14,138
    Market Cap (Jan-05-2024)
    0.390 Billion USD
    World Rank (Jul-30-2023)
    12,951
    Market Cap (Jul-30-2023)
    0.485 Billion USD
    World Rank (Dec-25-2022)
    14,430
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    13,051
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    50 Million USD
    Annual Operating Income in USD
    -49 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Lexicon Pharmaceuticals is a Biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize winning technology to discover and develop precise medicines for people with serious, chronic conditions. The company annual revenue is 322.07 million USD and 202 employees as on 2019. The headquarters is in USA.

Share

Ads